Column Group LLC Q1 2025 Filing

Filed May 14, 2025

Portfolio Value

$44.2B

Holdings

5

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ORICORIC Pharmaceuticals Inc.
3,540,777$19.8B44.67%
2
SRZNSurrozen, Inc.
1,499,773$17.5B39.54%
3
TNYATenaya Therapeutics, Inc.
9,400,290$5.4B12.12%
4
RAPTEURRAPT Therapeutics Inc
1,328,613$1.6B3.67%
5
RVMDRevolution Medicines Inc
46$1.6M0.00%